Loading
Luyan Pharma Co.,Ltd.: what insiders have been doing
Luyan Pharma Co.,Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). The past year has been quiet: not a single insider filing for Luyan Pharma Co.,Ltd. The previous disclosure was published on 28 November 2024.
Looking back to 2021, when coverage begins, insiders filed no purchases and 9 sales.
Other companies in the same sector with recent insider buying flagged by our signals: MAIA Biotechnology, Inc. and Cooper Companies, Inc. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
Insider Decl.
9
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€831,192
9 ops. · all time
Who traded when
BuySale雷鸣1 sale
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 14,242 of 24,161 companies
46.3
score / 100
Value67
Quality26
FCF yld11%
Earn yld6.7%
EV/EBITDA13.1x
ROE8.1%
Gross mgn7.1%
Net mgn1.3%
Debt/EBITDA7.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
CN¥10.76
Analyst consensus
Income statement
RevenueCN¥21.2B
Gross profitCN¥1.5B7% margin
EBITDACN¥694.4M3% margin
Net incomeCN¥280.9M1.3% margin
Valuation
PER (trailing)15.6x
P/Book1.3x
Beta-0.01
Balance sheet & cash
Market capCN¥4.2B
Total debtCN¥4.9B
Free Cash FlowCN¥454.7M
Debt / Equity159%
Profitability & ownership
ROE8.1%
ROA2.7%
% insiders41.9%
% institutions0.6%
Last declaration on 28 November 2024
Declarations9 total
9 of 9 declarations
About Luyan Pharma Co.,Ltd.
鹭燕医药 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHE market. It focuses on the development and distribution of pharmaceutical products.
